ME Therapeutics
Vancouver
About ME Therapeutics
ME Therapeutics is a biotechnology company that focuses on discovery and development of Myeloid cell targeted immuno oncology drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $1.2M
- Funding stage: IPO
- Last round: Grant (May 2025)
- Ticker: cse:METX
- Website: metherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/me-therapeutics-36392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.